480896
Last Update Posted: 2014-09-18
Recruiting has ended
All Genders accepted | 2 Years-15 Years |
250 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment
A long-term 0.03% tacrolimus ointment based regimen comprising of up to 6 weeks of initial twice daily treatment and subsequent twice weekly prophylactic application can effectively treat active lesions of atopic dermatitis, and prevent, delay, and reduce flares.
Eligibility
Relevant conditions:
Dermatitis, Atopic
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov